Pro Dex Inc (PDEX) stock

PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/304% below fair value

$67.42−4.07 (-5.69%)

Close on Nov 12, 2026Market cap $215.74MP/E 18.6Yield –

Pro Dex EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Pro Dex's EV/EBITDA was 16.1× on Nov 11, 2026, against 9.7× a year earlier. Over the last 5 years it ranged from 7.2× to 19.2×, with a median of 10.9×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	16.1×	+5.8
2025	Dec 31, 2025	10.3×	−6.2
2024	Dec 31, 2024	16.5×	+8.7
2023	Dec 29, 2023	7.8×	−2.0
2022	Dec 30, 2022	9.8×	−8.3
2021	Dec 31, 2021	18.1×	+3.1
2020	Dec 31, 2020	15.0×	+2.7
2019	Dec 31, 2019	12.3×	+0.4
2018	Dec 31, 2018	11.9×	+5.8
2017	Dec 29, 2017	6.1×	−3.6
2016	Dec 30, 2016	9.7×	+8.9
2012	Jul 31, 2012	0.8×	−0.0
2011	Dec 30, 2011	0.8×	–